Investment Analysts’ Updated EPS Estimates for February 6th (ACET, AIOT, ALGN, AMN, AMTM, ARES, ARM, ARMK, BSX, CCRN)

Investment Analysts’ updated eps estimates for Thursday, February 6th:

Adicet Bio (NASDAQ:ACET) had its market perform rating reissued by analysts at JMP Securities.

Powerfleet (NASDAQ:AIOT) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $15.00 target price on the stock.

Align Technology (NASDAQ:ALGN) had its hold rating reissued by analysts at Needham & Company LLC.

AMN Healthcare Services (NYSE:AMN) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $34.00 price target on the stock.

Amentum (NYSE:AMTM) had its sector perform rating reiterated by analysts at Royal Bank of Canada. They currently have a $24.00 price target on the stock.

Ares Management (NYSE:ARES) had its market perform rating reaffirmed by analysts at JMP Securities.

ARM (NASDAQ:ARM) had its hold rating reissued by analysts at Needham & Company LLC.

ARM (NASDAQ:ARM) had its hold rating reaffirmed by analysts at Benchmark Co..

Aramark (NYSE:ARMK) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $47.00 price target on the stock.

Boston Scientific (NYSE:BSX) had its hold rating reiterated by analysts at Needham & Company LLC.

Cross Country Healthcare (NASDAQ:CCRN) had its market perform rating reissued by analysts at JMP Securities.

Clene (NASDAQ:CLNN) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $23.00 target price on the stock.

Coty (NYSE:COTY) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $12.50 target price on the stock.

Coya Therapeutics (NASDAQ:COYA) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $15.00 target price on the stock.

Salesforce (NYSE:CRM) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $400.00 price target on the stock.

Criteo (NASDAQ:CRTO) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $61.00 price target on the stock, up from their previous price target of $59.00.

CSG Systems International (NASDAQ:CSGS) had its outperform rating reissued by analysts at Northland Securities. Northland Securities currently has a $80.00 price target on the stock, up from their previous price target of $78.00.

Cognizant Technology Solutions (NASDAQ:CTSH) had its hold rating reissued by analysts at Needham & Company LLC.

Carvana (NYSE:CVNA) had its neutral rating reiterated by analysts at Wedbush. They currently have a $250.00 target price on the stock.

Carvana (NYSE:CVNA) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $300.00 price target on the stock.

Cytokinetics (NASDAQ:CYTK) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $72.00 price target on the stock.

DoorDash (NASDAQ:DASH) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $200.00 price target on the stock.

Dayforce (NYSE:DAY) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $95.00 price target on the stock.

Digi International (NASDAQ:DGII) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $45.00 price target on the stock.

DHI Group (NYSE:DHX) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $7.00 target price on the stock.

Dynatrace (NYSE:DT) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Dynatrace (NYSE:DT) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $67.00 price target on the stock.

Dynatrace (NYSE:DT) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $57.00 target price on the stock.

Emerson Electric (NYSE:EMR) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $138.00 price target on the stock.

The Ensign Group (NASDAQ:ENSG) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $155.00 target price on the stock.

Equinix (NASDAQ:EQIX) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $1,200.00 price target on the stock.

Equinor ASA (NYSE:EQNR) had its sector perform rating reissued by analysts at Royal Bank of Canada.

Essex Property Trust (NYSE:ESS) had its market perform rating reiterated by analysts at JMP Securities.

Eyenovia (NASDAQ:EYEN) had its neutral rating reiterated by analysts at HC Wainwright. The firm currently has a $2.00 price target on the stock.

EyePoint Pharmaceuticals (NASDAQ:EYPT) had its buy rating reiterated by analysts at Chardan Capital. They currently have a $33.00 target price on the stock.

EZCORP (NASDAQ:EZPW) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $13.50 target price on the stock.

FormFactor (NASDAQ:FORM) had its hold rating reiterated by analysts at Needham & Company LLC.

Griffon (NYSE:GFF) had its strong-buy rating reaffirmed by analysts at Raymond James. The firm currently has a $95.00 target price on the stock, up from their previous target price of $92.00.

Globus Medical (NYSE:GMED) had its hold rating reiterated by analysts at Needham & Company LLC.

Grindr (NYSE:GRND) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $21.00 price target on the stock.

Hologic (NASDAQ:HOLX) had its overweight rating reissued by analysts at Stephens. They currently have a $84.00 target price on the stock.

Hologic (NASDAQ:HOLX) had its outperform rating reaffirmed by analysts at Raymond James. Raymond James currently has a $90.00 target price on the stock, down from their previous target price of $95.00.

Hologic (NASDAQ:HOLX) had its outperform rating reiterated by analysts at William Blair.

HealthStream (NASDAQ:HSTM) had its market perform rating reaffirmed by analysts at JMP Securities.

Immuneering (NASDAQ:IMRX) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $12.00 price target on the stock.

Innate Pharma (NASDAQ:IPHA) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $11.50 price target on the stock.

Kulicke and Soffa Industries (NASDAQ:KLIC) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $53.00 price target on the stock.

Coca-Cola (NYSE:KO) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $69.00 target price on the stock.

Kura Oncology (NASDAQ:KURA) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $28.00 target price on the stock.

Moelis & Company (NYSE:MC) had its market perform rating reissued by analysts at JMP Securities.

Moelis & Company (NYSE:MC) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $92.00 target price on the stock, up from their previous target price of $86.00.

Microchip Technology (NASDAQ:MCHP) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $90.00 target price on the stock.

Marsh & McLennan Companies (NYSE:MMC) had its outperform rating reaffirmed by analysts at Raymond James. The firm currently has a $250.00 price target on the stock, up from their previous price target of $240.00.

Molina Healthcare (NYSE:MOH) had its equal weight rating reaffirmed by analysts at Stephens. Stephens currently has a $345.00 price target on the stock.

Monolithic Power Systems (NASDAQ:MPWR) had its neutral rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $880.00 target price on the stock.

Envista (NYSE:NVST) had its hold rating reiterated by analysts at Needham & Company LLC.

Old Dominion Freight Line (NASDAQ:ODFL) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $240.00 target price on the stock.

OptimizeRx (NASDAQ:OPRX) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $8.00 price target on the stock.

Peloton Interactive (NASDAQ:PTON) had its hold rating reiterated by analysts at Needham & Company LLC.

Paycor HCM (NASDAQ:PYCR) had its market perform rating reissued by analysts at JMP Securities.

QUALCOMM (NASDAQ:QCOM) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $250.00 target price on the stock.

QUALCOMM (NASDAQ:QCOM) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $160.00 price target on the stock.

TransCode Therapeutics (NASDAQ:RNAZ) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $20.00 target price on the stock.

Recursion Pharmaceuticals (NASDAQ:RXRX) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $11.00 price target on the stock.

Safehold (NYSE:SAFE) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $35.00 price target on the stock.

Saia (NASDAQ:SAIA) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $600.00 target price on the stock.

Steven Madden (NASDAQ:SHOO) had its hold rating reaffirmed by analysts at Needham & Company LLC.

SiTime (NASDAQ:SITM) had its outperform rating reaffirmed by analysts at Raymond James. The firm currently has a $250.00 price target on the stock, up from their previous price target of $215.00.

Stewart Information Services (NYSE:STC) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $82.00 price target on the stock.

STERIS (NYSE:STE) had its overweight rating reissued by analysts at Stephens. The firm currently has a $240.00 price target on the stock.

STERIS (NYSE:STE) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $265.00 price target on the stock.

Skyworks Solutions (NASDAQ:SWKS) had its hold rating reissued by analysts at Benchmark Co..

Skyworks Solutions (NASDAQ:SWKS) had its neutral rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $80.00 target price on the stock, down from their previous target price of $120.00.

Skyworks Solutions (NASDAQ:SWKS) had its hold rating reissued by analysts at Needham & Company LLC.

Symbotic (NASDAQ:SYM) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $60.00 target price on the stock.

Tenable (NASDAQ:TENB) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $50.00 target price on the stock.

First Financial (NASDAQ:THFF) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $55.00 target price on the stock, up from their previous target price of $52.00.

T. Rowe Price Group (NASDAQ:TROW) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $113.00 target price on the stock, up from their previous target price of $111.00.

Under Armour (NYSE:UAA) had its market perform rating reissued by analysts at Telsey Advisory Group. They currently have a $10.00 target price on the stock.

Uber Technologies (NYSE:UBER) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $80.00 target price on the stock.

Uber Technologies (NYSE:UBER) had its market perform rating reiterated by analysts at JMP Securities.

Uber Technologies (NYSE:UBER) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $82.00 target price on the stock.

Viking Therapeutics (NASDAQ:VKTX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $102.00 price target on the stock.

VolitionRx (NYSE:VNRX) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $5.00 target price on the stock.

Workday (NASDAQ:WDAY) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $300.00 target price on the stock.

Workday (NASDAQ:WDAY) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $315.00 target price on the stock.

Western Union (NYSE:WU) had its market perform rating reissued by analysts at JMP Securities.

Yum! Brands (NYSE:YUM) had its hold rating reaffirmed by analysts at TD Cowen. They currently have a $140.00 target price on the stock.

Receive News & Ratings for Adicet Bio Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adicet Bio Inc and related companies with MarketBeat.com's FREE daily email newsletter.